Apogee Therapeutics, Inc.
APGE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$182 | -$84 | -$40 |
| Dep. & Amort. | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $23 | $6 | $2 |
| Change in WC | -$2 | $6 | $10 |
| Other Non-Cash | -$11 | -$3 | $11 |
| Operating Cash Flow | -$171 | -$75 | -$16 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$1 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$649 | -$304 | $0 |
| Inv. Sales/Matur. | $350 | $30 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$300 | -$274 | $0 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $0 |
| Stock Issued | $493 | $315 | $168 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $0 | $0 |
| Financing Cash Flow | $495 | $315 | $168 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $23 | -$33 | $152 |
| Supplemental Information | – | – | – |
| Beg. Cash | $119 | $152 | $0 |
| End Cash | $142 | $119 | $152 |
| Free Cash Flow | -$172 | -$75 | -$16 |